| Descriptor English: | Clozapine | ||||
| Descriptor Spanish: |
Clozapina
| ||||
| Descriptor Portuguese: | Clozapina | ||||
| Descriptor French: | Clozapine | ||||
| Entry term(s): |
Clozaril Leponex |
||||
| Tree number(s): |
D03.633.300.240.220 |
||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D003024 | ||||
| Scope note: | A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. |
||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
| Pharm Action: |
Serotonin Antagonists Antipsychotic Agents GABA Antagonists |
||||
| Registry Number: | J60AR2IKIC | ||||
| CAS Type 1 Name: | 5H-Dibenzo(b,e)(1,4)diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)- | ||||
| Previous Indexing: |
Dibenzazepines (1971-1974) Piperazines (1971-1974) |
||||
| Public MeSH Note: | 91; was see under DIBENZAZEPINES 1975-90 |
||||
| History Note: | 91(75); was see under DIBENZAZEPINES 1975-90 |
||||
| DeCS ID: | 3051 | ||||
| Unique ID: | D003024 | ||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
| Date Established: | 1991/01/01 | ||||
| Date of Entry: | 1974/11/19 | ||||
| Revision Date: | 2016/05/28 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
|
Clozapine
- Preferred
Clozaril
- Narrower
Leponex
- Narrower
| Concept UI |
M0004649 |
| Scope note | A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. |
| Preferred term | Clozapine |
| Concept UI |
M0354010 |
| Preferred term | Clozaril |
| Concept UI |
M0354009 |
| Preferred term | Leponex |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey